|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
2U54CA163071-06
|
$1,427,230
|
$313,991
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
|
(1/2) University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143727-08
|
$1,188,362
|
$213,905
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
$309,969
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
1R01CA216248-01
|
$565,675
|
$565,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
|
(Diversity supplement to R01CA188096) Targeting autophagaphy in hereditary breast cancer
|
3R01CA188096-03S1
|
$57,707
|
$57,707
|
XIA, BING
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
1R01CA216290-01
|
$338,903
|
$338,903
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-02
|
$637,172
|
$637,172
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
1R01CA219880-01
|
$697,539
|
$697,539
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
1R01CA216242-01
|
$318,277
|
$318,277
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
5R01CA205632-02
|
$457,974
|
$457,974
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
|
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
|
5R01CA205101-02
|
$388,402
|
$388,402
|
SKALA, MELISSA
|
MORGRIDGE INSTITUTE FOR RESEARCH, INC.
|
|
|
(PQ8) BONE MARROW-ON-A-CHIP:AN INVITRO 3D MODEL OF BREAST CANCER DORMANCY
|
7R21CA208519-02
|
$199,013
|
$199,013
|
GEORGE, STEVEN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
7R01CA208765-02
|
$356,362
|
$356,362
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
|
(PQ9) Characterization and prophylactic treatment of chemotherapy-induced long-term adverse sequelae
|
5R01CA208634-02
|
$560,277
|
$280,139
|
JURECIC, ROLAND
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
(PQ9) Dual Action RSK Inhibitor: Targeting Metastasis and Providing Cardioprotection
|
5R21CA208631-02
|
$137,120
|
$137,120
|
LANNIGAN, DEBORAH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle
|
5R21CA205437-03
|
$168,236
|
$168,236
|
WANING, DAVID
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-02
|
$577,463
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
|
(PQA2) Exploring the role of sarcopenia in obesity and breast cancer survival
|
5R01CA184953-04
|
$607,944
|
$607,944
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
5R01CA185293-04
|
$329,104
|
$329,104
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
|
(PQA2): Escape from breast tumor dormancy: convergence of obesity and menopause
|
5R01CA185530-04
|
$367,275
|
$367,275
|
MOSES, MARSHA
|
BOSTON CHILDREN'S HOSPITAL
|
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
5R01CA179992-04
|
$909,181
|
$909,181
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-04
|
$329,925
|
$108,875
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-03
|
$446,627
|
$147,387
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
5R01CA185363-04
|
$318,250
|
$318,250
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-03
|
$675,664
|
$675,664
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
|
5R01CA185138-04
|
$490,842
|
$490,842
|
HWANG, EUN-SIL
|
DUKE UNIVERSITY
|
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
5R01CA185086-04
|
$423,327
|
$423,327
|
VASUDEVAN, SHOBHA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-03
|
$347,700
|
$347,700
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
|
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care
|
5R01CA190016-04
|
$617,350
|
$617,350
|
NATTINGER, ANN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$627,926
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
|
5R01CA195904-03
|
$555,499
|
$555,499
|
MURPHY, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202924-02
|
$229,982
|
$149,488
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-08
|
$1,258,708
|
$276,916
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
1P20CA202920-01A1
|
$301,537
|
$301,537
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
1/2 The GUIDE Cancer Research Training Project
|
5P20CA202908-03
|
$222,320
|
$222,320
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-03
|
$1,192,293
|
$655,761
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-02
|
$255,626
|
$61,350
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
$257,452
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
$447,202
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
1P20CA202922-01A1
|
$255,957
|
$255,957
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-03S1
|
$52,412
|
$52,412
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-03
|
$174,056
|
$174,056
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
$114,150
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-03
|
$820,604
|
$303,623
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
|
2017 Mammary Gland Biology Gordon Research Conference & Gordon Research Seminar
|
1R13CA216888-01
|
$10,000
|
$10,000
|
FORD, HEIDE
|
GORDON RESEARCH CONFERENCES
|
|
|
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
|
5R01CA203984-02
|
$686,225
|
$686,225
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
3R01CA188991-03S1
|
$33,291
|
$33,291
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
5R01CA188991-03
|
$304,709
|
$304,709
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
$105,348
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202997-03
|
$1,314,319
|
$78,859
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Total relevant funding to Breast for this search: $545,149,951
|
